Výsledky vyhledávání - "N Iu, Lashch"

[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case]

Autor: M V, Mel'nikov, O V, Boĭko, N Iu, Lashch, E V, Popova, M Iu, Martynov, A N, Boĭko

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 112(9 Pt 2)

Clinical features and MRI-characteristics of two demyelinating diseases: acute disseminated encephalomyelitis (ADEM) and multiple sclerosis (MS) are discussed. Despite the seeming obviousness of differential-diagnostic criteria, the individual course

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17ac5b641de238a2b5dc8d1c6313f7ef
https://pubmed.ncbi.nlm.nih.gov/23235425

Zobrazit plný text záznamu

[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]

Autor: E Iu, Tsareva, O G, Kulakova, O Iu, Makarycheva, A N, Boĭko, S G, Shchur, N Iu, Lashch, N F, Popova, E I, Gusev, V V, Bashinskaia, D V, L'vov, A V, Favorov, M F, Ochs, O O, Favorova

Publikováno v: Molekuliarnaia biologiia. 45(6)

Complex association analysis of copaxone (glatiramer acetate) immunotherapy efficacy with allelic polymorphism in the number of immune response genes, which encode interferone beta (IFNB1), transforming growth factor beta1 (TGFB1), interferone gamma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9fcc373fe31764f4862e4d10dc555a83
https://pubmed.ncbi.nlm.nih.gov/22295566

Zobrazit plný text záznamu

[Instrumental methods of the rehabilitation of motor disorders in patients with multiple sclerosis]

Autor: Iu A, Klimov, A N, Boĭko, N F, Popova, N Iu, Lashch, A V, Petrov, V V, Ovcharov, S N, Sharanova, O V, Riabukhina, E F, Krynkina, T T, Batysheva, A V, Romashkin

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)

Motor and coordination disorders are the most prominent clinical presentations of multiple sclerosis. Currently, good results were achieved in the pathogenetic treatment of the disease. However methods of treatment of motor and coordination disorders

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b5ffc0c4f902df2a42da813e561de55d
https://pubmed.ncbi.nlm.nih.gov/21916161

Zobrazit plný text záznamu

[The use of rebif in the Moscow Municipal Multiple Sclerosis Center]

Autor: E V, Popova, A N, Boĭko, M F, Davydovskaia, T L, Demina, N Iu, Lashch, N F, Popova, N V, Khachanova, S G, Shchur, E I, Gusev

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)

We summarized the 3-year experience of using beta-interferon 1a (44 mcg, subcutaneously) in the form of the preparation rebif in 141 patients including 120 patients with active remitting multiple sclerosis (RMS) and 21 patients with secondary progres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::56eb98e429de58f55681f1543b8fa416
https://pubmed.ncbi.nlm.nih.gov/21916159

Zobrazit plný text záznamu

[The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy]

Autor: A N, Boĭko, M F, Davydovskaia, T L, Demina, N Iu, Lashch, V V, Ovcharov, N F, Popova, N I, Sinbukhova, N V, Khachanova, S G, Shchur, E I, Gusev

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

In last decades, practical neurologists are able to use DMT in multiple sclerosis (MS) in every day practice. This paper presents data of 3-year study of DMT (copaxone and betaferon) treatment of 280 patients with definite diagnosis of multiple scler

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4d1cdfb05805377731a0fed3a741b9f9
https://pubmed.ncbi.nlm.nih.gov/17172244

Zobrazit plný text záznamu

[Use of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience of the Moscow multiple sclerosis center]

Autor: T L, Demina, M V, Davydovskaia, N Iu, Lashch, N F, Popova, N V, Khachanova, T D, Zhuchenko

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)

146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre. The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment. EDSS score did not increase both in group with and w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::994fbe4c7ff85fd69bb43801484e49ef
https://pubmed.ncbi.nlm.nih.gov/12938642

Zobrazit plný text záznamu

[The role of the peripheral nervous system damage in clinical picture of multiple sclerosis]

Autor: E I, Gusev, N Iu, Lashch, A N, Boĭko, T L, Demina

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)

Multiple sclerosis (MS) was believed to be an autoimmune disease of central nervous system (CNS). Recently, several studies showing early involvement of peripheral nervous system (PNS) in MS pathological process have been published. This review own a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::49ced962e73bfb71d51e85dd3f9a9862
https://pubmed.ncbi.nlm.nih.gov/12938634

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání